Skip to main content

Technical Assistance Webinar for Funding Opportunity Announcements PAR 22-115 and PAR 22-120

March 17, 2022 | 3:00 pm - 4:30 pm (ET) | via Zoom

Research on Community Level Interventions for Firearm and Related Violence Injury and Mortality Prevention (CLIF-VP)

The NIH Office of Behavioral and Social Sciences Research is holding a technical assistance webinar related to the recently released funding opportunity announcements (FOA) PAR 22-115 and PAR 22-120: Research on Community Level Interventions for Firearm and Related Violence Injury and Mortality Prevention (CLIF-VP)

  • FOA PAR 22-115 solicits bi-phasic research projects proposed in UG3/UH3 Phased Innovation Awards Cooperative Agreement applications. Funding for the UG3 phase (phase I) will be used to demonstrate sufficient preparation, feasibility and capacity to meet foundational milestone targets specific to the work proposed. A UG3 project that meets its milestones will be administratively considered by NIH and prioritized for transition to the UH3 award (phase II). Applicants responding to this FOA must address specific aims and milestones for both the UG3 and UH3 phases.

  • FOA PAR 22-120 seeks applications for a Coordinating Center (CC) for Community-Level Interventions for Firearm Violence Prevention (CLIF-VP) Research Network. The CLIF-VP Research Network will include the CC funded under this Cooperative Agreement and up to 10 Research Projects funded under the companion UG3/UH3 Phased Cooperative Agreement FOA, Research on Community Level Interventions for Firearm and Related Violence, Injury, and Mortality Prevention (CLIF-VP) PAR-22-115. The CC will provide overarching support and guidance to the network in three domains: (1) administration, coordination, and communication; (2) data, measurement, and analytic support and consultation; and (3) public/stakeholder engagement and dissemination support.

The webinar will provide an overview of the FOAs and provide an opportunity to address participant questions. NIH staff will discuss the purpose and scope of these funding opportunities, go over the scientific review process, and review criteria and other logistical information.